Covington & Burling (Washington)

Mark Lynch

Covington & Burling (Washington)
Lawyer (Of Counsel)

Mark H. Lynch is Co-Chair of the firm’s Pharmaceutical Litigation and Government Investigations Group. He has tried cases and argued appeals involving a wide variety of civil and criminal matters in state and federal courts throughout the country, including the US Supreme Court. In recent years, his practice has focused on representation of pharmaceutical manufacturers in complex, multi-district civil litigation involving parallel state and federal proceedings which are often triggered by government investigations. Mr. Lynch has defended major pharmaceutical companies in class actions challenging pricing practices and in nationwide product liability litigation. He has experience in various types of fraud and breach of fiduciary duty cases, RICO, grand jury investigations, internal corporate investigations, and product liability litigation.

Linked authors

Covington & Burling (Brussels)
Covington & Burling (Brussels)
Covington & Burling (Brussels)
Covington & Burling (Washington)
Covington & Burling (Palo Alto)

Articles

22 Bulletin

Michael Labson, Geoffrey Hobart, Eric Holder, Mark Lynch, Richard Kingham, Peter Safir, Theodore Voorhees Jr, James R. Dean, David W. Addis, Ethan M. Posner The US FTC announces its intention to conduct an extensive study of the economic effects of authorized generic pharmaceuticals

22

On April 4, 2006, the FTC published notice of its intention to conduct an extensive study of the economic effects of authorized generic pharmaceuticals. See 71 Fed. Reg. 16,779 (April 4, 2006). The initial stage of the study would involve detailed information requests, akin to subpoenas, to as (...)

Send a message